Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil EL&P Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries Olympus Corp ADR (OP: OCPNY ) N/A UNCHANGED Last Price Updated: 2:34 PM EST, Jan 31, 2023 Add to My Watchlist Quote Overview Detailed Quote Charting Historical Prices News All News News Headlines Press Releases Research Quarterly Reports Insider Filings Other Filings All News about Olympus Corp ADR NTT and Olympus Begin World's First Joint Demonstration Experiment of Cloud Endoscopy System March 27, 2024 From Olympus Via JCN Newswire Olympus Closes the Acquisition of Korean Gastrointestinal Stent Company, Taewoong Medical Co., Ltd January 24, 2024 From Olympus Via JCN Newswire Olympus Names Dr. John de Csepel as Chief Medical Officer October 03, 2023 From Olympus Via JCN Newswire Olympus to Launch Development Support Project in Kenya for the Diagnosis of Gastrointestinal Diseases July 19, 2023 From Olympus Via JCN Newswire Olympus Announces Plan to Establish Digital Excellence Centers Following Acquisition of Cloud-AI Endoscopy Startup Odin Vision June 05, 2023 From Olympus Via JCN Newswire Olympus Names Wenlei Yang the Newly Established Chief Diversity, Equity and Inclusion Officer May 29, 2023 From Olympus Via JCN Newswire Olympus to Acquire Korean Gastrointestinal Stent Company Taewoong Medical Co., Ltd February 24, 2023 From Olympus Via JCN Newswire Olympus Named to Dow Jones Sustainability World Index for Two Consecutive Years December 15, 2022 From Olympus Via JCN Newswire Olympus Announces Launch of Olympus Asia Pacific Innovation Program December 04, 2022 From Olympus Via JCN Newswire Olympus to Join Government Project to Verify Dissemination of Endoscopic AI Diagnosis in Vietnam December 06, 2022 Via JCN Newswire Topics Artificial Intelligence Exposures Artificial Intelligence Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.
